Evaluation of Stress Dose Hydrocortisone Tapers in Septic Shock.

IF 0.7 Q4 PHARMACOLOGY & PHARMACY
Hannah Elizabeth Gilchrist, Matthew Roginski, Alyson Esteves
{"title":"Evaluation of Stress Dose Hydrocortisone Tapers in Septic Shock.","authors":"Hannah Elizabeth Gilchrist, Matthew Roginski, Alyson Esteves","doi":"10.1177/00185787251355438","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> Stress dose hydrocortisone is recommended in septic shock. Discontinuation can lead to withdrawal after prolonged durations of therapy. There is no guidance on the use of steroid tapers. Our objective was to assess prescribing practices and evaluate stress dose hydrocortisone tapers in septic shock. <b>Methods:</b> Retrospective review of patients admitted to the intensive care unit (ICU), with septic shock, who received hydrocortisone for at least 24 hours from January 1, 2020 through December 31, 2023. The primary outcome was the percentage of patients who received a hydrocortisone taper. Secondary outcomes included duration of stress dose hydrocortisone, method and duration of taper, and rate of increased vasopressors at 24 and 48 hours of hydrocortisone taper initiation or discontinuation. <b>Results:</b> Two hundred seventy-six patients were included. The initial duration of hydrocortisone was 2 (1.5-3) days. One hundred thirty-nine (50.4%) patients received a hydrocortisone taper, with a taper duration of 2 (1-3) days. The primary method of taper was a reduction in frequency (56.8%). Patients who received a taper required an increase in vasopressor rate at 24 (37.4% vs 21.3%, <i>P</i> = .004) and 48 hours (20.3% vs 12.9%; <i>P</i> = .14). The steroid taper group showed a decreased hospital (OR 0.55; 95% CI, 0.33-0.92) and ICU mortality rate (OR 0.47; 95% CI, 0.27-0.81), albeit an increased ICU length of stay (OR 1.04; 95% CI, 1.02-1.06), increased duration of mechanical ventilation (OR 1.08; 95% CI, 1.03-1.12), and increased vasopressor rate at 24 hours (OR 2.21; 95% CI, 1.29-3.77). <b>Conclusions:</b> In patients admitted to an ICU for septic shock started on stress dose hydrocortisone there was heterogeneity in the duration of stress dose hydrocortisone and the implementation, method, and length of a taper. This highlights a need for additional attention to methods of discontinuation of stress dose steroids and implications on patient centered outcomes.</p>","PeriodicalId":13002,"journal":{"name":"Hospital Pharmacy","volume":" ","pages":"00185787251355438"},"PeriodicalIF":0.7000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12259595/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/00185787251355438","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Stress dose hydrocortisone is recommended in septic shock. Discontinuation can lead to withdrawal after prolonged durations of therapy. There is no guidance on the use of steroid tapers. Our objective was to assess prescribing practices and evaluate stress dose hydrocortisone tapers in septic shock. Methods: Retrospective review of patients admitted to the intensive care unit (ICU), with septic shock, who received hydrocortisone for at least 24 hours from January 1, 2020 through December 31, 2023. The primary outcome was the percentage of patients who received a hydrocortisone taper. Secondary outcomes included duration of stress dose hydrocortisone, method and duration of taper, and rate of increased vasopressors at 24 and 48 hours of hydrocortisone taper initiation or discontinuation. Results: Two hundred seventy-six patients were included. The initial duration of hydrocortisone was 2 (1.5-3) days. One hundred thirty-nine (50.4%) patients received a hydrocortisone taper, with a taper duration of 2 (1-3) days. The primary method of taper was a reduction in frequency (56.8%). Patients who received a taper required an increase in vasopressor rate at 24 (37.4% vs 21.3%, P = .004) and 48 hours (20.3% vs 12.9%; P = .14). The steroid taper group showed a decreased hospital (OR 0.55; 95% CI, 0.33-0.92) and ICU mortality rate (OR 0.47; 95% CI, 0.27-0.81), albeit an increased ICU length of stay (OR 1.04; 95% CI, 1.02-1.06), increased duration of mechanical ventilation (OR 1.08; 95% CI, 1.03-1.12), and increased vasopressor rate at 24 hours (OR 2.21; 95% CI, 1.29-3.77). Conclusions: In patients admitted to an ICU for septic shock started on stress dose hydrocortisone there was heterogeneity in the duration of stress dose hydrocortisone and the implementation, method, and length of a taper. This highlights a need for additional attention to methods of discontinuation of stress dose steroids and implications on patient centered outcomes.

应激剂量氢化可的松锥在感染性休克中的评价。
简介:脓毒性休克推荐使用应激剂量氢化可的松。停药可导致长时间治疗后的停药。没有关于使用类固醇减肥药的指南。我们的目的是评估处方做法和评估应激剂量氢化可的松逐渐减少在感染性休克。方法:回顾性分析2020年1月1日至2023年12月31日入住重症监护病房(ICU),接受氢化可的松治疗至少24小时的脓毒性休克患者。主要结果是接受氢化可的松逐渐减少治疗的患者百分比。次要结果包括应激剂量氢化可的松持续时间,逐渐减少的方法和持续时间,以及在氢化可的松逐渐减少开始或停止的24和48小时时血管加压素增加的比率。结果:共纳入276例患者。氢化可的松初始疗程为2(1.5-3)天。139例(50.4%)患者接受了氢化可的松减量治疗,减量时间为2(1-3)天。锥度的主要方法是减少频率(56.8%)。接受减量治疗的患者在24小时(37.4% vs 21.3%, P = 0.004)和48小时(20.3% vs 12.9%;p = .14)。类固醇锥度组住院率降低(OR 0.55;95% CI, 0.33-0.92)和ICU死亡率(OR 0.47;95% CI, 0.27-0.81),尽管ICU住院时间增加(OR 1.04;95% CI, 1.02-1.06),机械通气持续时间增加(OR 1.08;95% CI, 1.03-1.12), 24小时血管加压率升高(OR 2.21;95% ci, 1.29-3.77)。结论:在接受应激剂量氢化可的松治疗的脓毒性休克入住ICU的患者中,应激剂量氢化可的松治疗的持续时间、实施、方法和逐渐减少的长度存在异质性。这突出了需要额外关注应激剂量类固醇的停药方法及其对以患者为中心的结果的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hospital Pharmacy
Hospital Pharmacy PHARMACOLOGY & PHARMACY-
CiteScore
1.70
自引率
0.00%
发文量
63
期刊介绍: Hospital Pharmacy is a monthly peer-reviewed journal that is read by pharmacists and other providers practicing in the inpatient and outpatient setting within hospitals, long-term care facilities, home care, and other health-system settings The Hospital Pharmacy Assistant Editor, Michael R. Cohen, RPh, MS, DSc, FASHP, is author of a Medication Error Report Analysis and founder of The Institute for Safe Medication Practices (ISMP), a nonprofit organization that provides education about adverse drug events and their prevention.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信